...
首页> 外文期刊>Stem cells international >Zebularine Promotes Hepatic Differentiation of Rabbit Bone Marrow Mesenchymal Stem Cells by Interfering with p38 MAPK Signaling
【24h】

Zebularine Promotes Hepatic Differentiation of Rabbit Bone Marrow Mesenchymal Stem Cells by Interfering with p38 MAPK Signaling

机译:Zebularine通过干扰p38 MAPK信号传导促进兔骨髓间充质干细胞的肝分化

获取原文

摘要

Demethylating agent zebularine is reported to be capable of inducing differentiation of stem cells by activation of methylated genes, though its function in hepatocyte differentiation is unclear. p38 signal pathway is involved in differentiation of hepatocytes and regulating of DNA methyltransferases 1 (DNMT1) expression. However, little is known about the impact of zebularine on bone marrow mesenchymal stem cells (BMMSCs) and p38 signaling during hepatic differentiation. The present study investigated the effects of zebularine on hepatic differentiation of rabbit BMMSCs, as well as the role of p38 on DNMT1 and hepatic differentiation, with the aim of developing a novel strategy for improving derivation of hepatocytes. BMMSCs were treated with zebularine at concentrations of 10, 20, 50, and 100 μM in the presence of hepatocyte growth factor; changes in the levels of hepatic-specific alpha-fetoprotein and albumin were detected and determined by RT-PCR, WB, and immunofluorescence staining. Expression of DNMT1 and phosphorylated p38 as well as urea production and ICG metabolism was also analyzed. Zebularine at concentrations of 10, 20, and 50 μM could not affect cell viability after 48 h. Zebularine treatment leads to an inhibition of DNMT activity and increase of hepatic-specific proteins alpha-fetoprotein and albumin in BMMSCs in vitro; zebularine addition also induced expression of urea production of and ICG metabolism. p38 signal was activated in BMMSCs simulated with HGF; inhibition of p38 facilitated the synthesis of DNMT1 and albumin in cells. Zebularine restrained DNMT1 and phosphorylated p38 which were induced by HGF. Therefore, this study demonstrated that treatment with zebularine exhibited terminal hepatic differentiation of BMMSCs in vitro in association with hepatocyte growth factor; p38 pathway at least partially participates in zebularine-induced hepatic differentiation of rabbit BMMSCs.
机译:据报道,去甲基化剂zebularine能够通过激活甲基化基因来诱导干细胞分化,尽管尚不清楚其在肝细胞分化中的作用。 p38信号通路参与肝细胞的分化和DNA甲基转移酶1(DNMT1)表达的调节。然而,关于zebularine对肝分化过程中骨髓间充质干细胞(BMMSCs)和p38信号转导的影响知之甚少。本研究调查了zebularine对兔BMMSCs肝细胞分化的影响,以及p38对DNMT1和肝细胞分化的作用,目的是开发一种改善肝细胞衍生的新策略。在存在肝细胞生长因子的情况下,以10、20、50和100μm的浓度用zebularine处理BMMSC。通过RT-PCR,WB和免疫荧光染色检测并确定肝特异性α-甲胎蛋白和白蛋白水平的变化。还分析了DNMT1和磷酸化的p38的表达,以及尿素的产生和ICG代谢。浓度为10、20和50μm的Zebularine在48?h后不会影响细胞活力。 Zebularine治疗可抑制DNMT活性,并在体外使BMMSC中肝特异性蛋白甲胎蛋白和白蛋白增加; zebularine的添加还诱导尿素生成和ICG代谢的表达。在用HGF模拟的BMMSC中激活了p38信号;对p38的抑制促进了细胞中DNMT1和白蛋白的合成。 Zebularine抑制了HGF诱导的DNMT1和磷酸化的p38。因此,这项研究表明,zebularine治疗与肝细胞生长因子相关,在体外显示出BMMSC的终末肝分化。 p38途径至少部分参与了zebularine诱导的兔骨髓间充质干细胞的肝分化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号